U-40 Oral

U-40 Oral 2
Biliary 1

Fri. Jun 8, 2018 9:30 AM - 10:20 AM Room 7 (4F, 416+417)

Chairs: Shunichi Ariizumi (Department of Gastroenterological Surgery, Tokyo Women's Medical Univ.), Yuko Mataki (Kagoshima University, Department of Digestive Surgery)

+Add all to schedule

[U40-2-1] Methylated promotor DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma

^○Shuji Nakamoto, Keishi Yamashita, Kazuharu Igarashi, Nobuyasu Nishizawa, Shigenori Ei, Hiroshi Tajima, Takashi Kaizu, Yusuke Kumamoto, Masahiko Watanabe (Department of Surgery, University School of Medicine, Sagamihara, Japan)

[U40-2-2] Prognostic impact of precursor lesions of ampullary adenocarcinoma:
Intra-ampullary papillary tubular neoplasm versus flat dysplasia

^○Sunjong Han¹, Kee-Taek Jang², Dong Wook Choi¹, Seong Ho Choi¹, Jin Seok Heo¹, In Woong Han¹, Yung hun You¹, DaeJoon Park¹, Youngju Ryu¹ (1.Department of Surgery, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea, 2.Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea)

[U40-2-3] Prognostic significance of ductal negative margin with intraoperative frozen section examination in hilar cholangiocarcinoma

^○Kanechika Den, Ryusei Matsuyama, Nobuhiro Tsuchiya, Takashi Murakami, Yasuhiro Yabushita, Yu Sawada, Takefumi Kumamoto, Ryutaro Mori, Itaru Endo (Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan)

[U40-2-4] Is segmental resection sufficient for the treatment of extrahepatic cholangiocarcinoma?:
Comparison with pancreaticoduodenectomy using a propensity-score matching analysis

^○Sunjong Han, Seong Ho Choi, Dong Wook Choi, Jin Seok Heo, In Woong Han, Yung hun You, DaeJoon Park, Youngju Ryu (Department of Surgery, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea)

[U40-2-5] Promising combination therapy of gemcitabine and metronidazole for cholangiocarcinoma cancer stem cells

^○Makoto Kawamoto¹, Masayo Umebayashi², Hideya Onishi¹, Masafumi Nakamura³, Takashi Morisaki² (1.Department of Cancer Therapy and Research, Kyushu University, Fukuoka, Japan, 2.Fukuoka General Cancer Clinic, Fukuoka, Japan, 3.Department of Surgery and Oncology, Kyushu University, Fukuoka, Japan)

[U40-2-6] Proposal on the Minimal Number of Retrieved Regional Lymph Nodes for Accurate Staging of Extrahepatic Bile Duct Cancer and Clinical Validation of the Three-tier System of Lymph Node Staging (AJCC 8th edition)
-A Multinational Multicenter Retrospective Study -

^○Youngmin Han (Surgery, Seoul National University Hospital, Seoul, Republic of Korea)

Session information

U-40 Oral 2Biliary 1